Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Anika Therapeutics (ANIK) stocks in Canada
Learn how to easily invest in Anika Therapeutics stocks.
Anika Therapeutics is a medical devices business based in the US. Anika Therapeutics stocks (ANIK.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $42.74 – a decrease of 1.53% over the previous week. Anika Therapeutics employs 277 staff and has a trailing 12-month revenue of around $144.7 million.
How to buy shares in Anika Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ANIK – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Anika Therapeutics?
- Has coronavirus impacted Anika Therapeutics shares?
- Anika Therapeutics shares summary
- Compare share dealing platforms
- Is Anika Therapeutics stock a buy or sell?
- Anika Therapeutics performance over time
- Are Anika Therapeutics shares over-valued?
- Anika Therapeutics's financials
- How volatile are Anika Therapeutics shares?
- Does Anika Therapeutics pay a dividend?
- Other common questions
Anika Therapeutics stock price (NASDAQ:ANIK)Use our graph to track the performance of ANIK stocks over time.
Anika Therapeutics shares at a glance
|Latest market close||$31.50|
|52-week range||$31.20 - $48.37|
|50-day moving average||$37.45|
|200-day moving average||$40.80|
|Wall St. target price||$50.75|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.40|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Anika Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Anika Therapeutics price performance over time
|1 week (2022-01-21)||-1.53%|
|1 month (2021-12-29)||-14.61%|
|3 months (2021-10-27)||-23.75%|
|6 months (2021-07-29)||-23.41%|
|1 year (2021-01-29)||-14.89%|
|2 years (2020-01-28)||-30.33%|
|3 years (2019-01-28)||37.05|
|5 years (2017-01-27)||50.13|
Is Anika Therapeutics under- or over-valued?
Valuing Anika Therapeutics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Anika Therapeutics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Anika Therapeutics's PEG ratio
Anika Therapeutics's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.1868. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Anika Therapeutics's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Anika Therapeutics's EBITDA
Anika Therapeutics's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $8.4 million.
The EBITDA is a measure of a Anika Therapeutics's overall financial performance and is widely used to measure a its profitability.
Anika Therapeutics financials
|Revenue TTM||$144.7 million|
|Gross profit TTM||$80.1 million|
|Return on assets TTM||-0.93%|
|Return on equity TTM||-1.99%|
|Market capitalisation||$475 million|
TTM: trailing 12 months
Anika Therapeutics share dividends
We're not expecting Anika Therapeutics to pay a dividend over the next 12 months.
Anika Therapeutics share price volatility
Over the last 12 months, Anika Therapeutics's shares have ranged in value from as little as $31.2 up to $48.37. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Anika Therapeutics's is 1.1242. This would suggest that Anika Therapeutics's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Anika Therapeutics overview
Anika Therapeutics, Inc. , together with its subsidiaries, operates as a joint preservation company that in the United States, Europe, and internationally. The company's joint pain management products include Monovisc and Orthovisc, which are single- and multi-injection, hyaluronic acid (HA)-based viscosupplements to provide pain relief from osteoarthritis (OA) conditions; Cingal, a novel, third-generation, single-injection OA product consisting of its proprietary cross-linked HA material combined with a steroid to provide short- and long-term pain relief; and Hyvisc, an injectable HA veterinary product for the treatment of joint dysfunction in horses. It also offers joint preservation and restoration products comprising preserving joint technologies, such as partial joint replacement, joint resurfacing, and minimally invasive and bone sparing implants to treat upper and lower extremity orthopedic conditions caused by trauma, injury, and arthritic disease; soft tissue repair solutions used by surgeons to repair and reconstruct damaged ligaments and tendons resulting from sports injuries, trauma, and disease; Tactoset, an HA-enhanced injectable bone repair therapy to treat insufficiency fractures; and Hyalofast, a biodegradable support for human bone marrow mesenchymal stem cells used for cartilage regeneration and as an adjunct for microfracture surgery. In addition, the company provides Hyalobarrier, an anti-adhesion barrier for use after abdomino-pelvic surgeries; Hyalomatrix for the treatment of complex wounds, such as burns and ulcers; products for the treatment of ears, nose, and throat disorder; and ophthalmic products, including injectables, high molecular weight HA products used as viscoelastic agents in ophthalmic surgical procedures, consisting of cataract extraction and intraocular lens implantation. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.
Stocks similar to Anika Therapeutics
Anika Therapeutics in the news
Ackman takes a big stake in Netflix, excited about company's long-term prospects
What to watch today: Stock futures turn positive, reversing big overnight losses
5 things to know before the stock market opens Thursday
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
How to buy Nauticus Robotics, Inc. (KITT) stock in Canada when it goes public
Everything we know about the Nauticus Robotics, Inc. IPO, plus information on how to buy in.
What is Mogo and how can you access its new trading platform, MogoTrade? Find out in our review.
Lido’s liquid staking allows investors holding LUNA and less than 32 ETH to reap the rewards of DeFi staking.
Bitcoin Private (BTCP) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Bitcoin Private, lists some exchanges where you can get it and provides daily price data on BTCP.
How to buy Haemonetics Corporation stock in Canada
Steps to owning and managing HAE stock, with 24-hour and historical pricing before you buy.
Go Auto Review
Use Go Auto to shop for new or used vehicles from multiple dealerships, with no hidden fees and access to bad credit financing.
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Hifi Finance (MFT) price prediction
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.